BIOLASE (NASDAQ:BIOL) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL) in a report released on Saturday. The brokerage issued a sell rating on the medical technology company’s stock.

BIOL has been the topic of a number of other reports. Benchmark restated a speculative buy rating and set a $0.40 target price on shares of BIOLASE in a report on Tuesday, May 14th. Maxim Group downgraded shares of BIOLASE from a strong-buy rating to a hold rating in a report on Friday, May 24th.

BIOLASE Trading Up 7.8 %

Shares of BIOL opened at $0.11 on Friday. The company has a market cap of $3.60 million, a price-to-earnings ratio of -0.01 and a beta of 0.71. BIOLASE has a 1-year low of $0.04 and a 1-year high of $10.31. The company’s fifty day simple moving average is $0.14 and its 200 day simple moving average is $0.39.

BIOLASE (NASDAQ:BIOL) last issued its earnings results on Monday, May 13th. The medical technology company reported ($0.36) earnings per share for the quarter. The firm had revenue of $10.13 million for the quarter. BIOLASE had a negative return on equity of 1,782.73% and a negative net margin of 43.56%.

Hedge Funds Weigh In On BIOLASE

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC lifted its holdings in BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 143,537 shares of the medical technology company’s stock after acquiring an additional 131,248 shares during the period. Virtu Financial LLC owned approximately 0.43% of BIOLASE worth $27,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 8.79% of the company’s stock.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.